Conceptus, Inc. (CPTS)

[Penny Roger$]

Conceptus, Inc. is engaged in the design, development, marketing and promotion of solutions in women’s healthcare. The Company’s product, Essure permanent birth control system, is a non-surgical permanent birth control system. The Essure system delivers a soft and flexible insert into a woman’s fallopian tubes, causing a benign tissue in-growth which blocks the fallopian tubes. Successfully placed Essure micro-inserts and the subsequent tissue growth around and through the micro-inserts prohibits the egg from traveling through the fallopian tube, preventing conception. During the year ended December 31, 2010, approximately 500,000 women worldwide had undergone the Essure procedure and it sold the Essure system in 31 countries. In October 2011, the Company acquired from its Dutch distributor certain assets and all distribution rights of the Essure device.

http://www.google.com/finance?q=CPTS